Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 93(14): 7381-6, 1996 Jul 09.
Article in English | MEDLINE | ID: mdl-8693002

ABSTRACT

Two families of peptides that specifically bind the extracellular domain of the human type I interleukin I (IL-1) receptor were identified from recombinant peptide display libraries. Peptides from one of these families blocked binding of IL-lalpha to the type I IL-1 receptor with IC50 values of 45-140 microM. Affinity-selective screening of variants of these peptides produced ligands of much higher affinity (IC50 approximately 2 nM). These peptides block IL-1-driven responses in human and monkey cells; they do not bind the human type II IL-1 receptor or the murine type I IL-1 receptor. This is the first example (that we know of) of a high affinity peptide that binds to a cytokine receptor and acts as a cytokine antagonist.


Subject(s)
Interleukin-1/metabolism , Peptides/chemistry , Peptides/pharmacology , Receptors, Interleukin-1/antagonists & inhibitors , Animals , Base Sequence , Binding, Competitive , Cell Line , Cells, Cultured , DNA Primers , Databases, Factual , Dinoprostone/metabolism , ErbB Receptors/biosynthesis , Escherichia coli , Haplorhini , Humans , Interleukin-1/pharmacology , Kinetics , Male , Mice , Molecular Sequence Data , Peptides/chemical synthesis , Polymerase Chain Reaction , Radioligand Assay , Receptors, Interleukin-1/biosynthesis , Recombinant Fusion Proteins/antagonists & inhibitors , Recombinant Fusion Proteins/biosynthesis , Skin/drug effects , Skin/immunology , Skin/metabolism , Spleen/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...